Evidence map›Paper›PMID 21280220›Full record

ArticleProteomics2011

Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity of the enzyme: Identification based on artifactual +80-Da modification at this site.

Adrian G Grozav, Belinda B Willard, Toshiyuki Kozuki, Kenichi Chikamori, Marius A Micluta, Andrei-Jose Petrescu, Michael Kinter, Ram Ganapathi, Mahrukh K Ganapathi

Abstract read
In one paragraph

Article in Proteomics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adrian G GrozavClinical Pharmacology Program, Taussig Cancer Institute, Cleveland, OH, USA.
Belinda B Willard
Toshiyuki Kozuki
Kenichi Chikamori
Marius A Micluta
Andrei-Jose Petrescu
Michael Kinter
Ram Ganapathi
Mahrukh K Ganapathi

Funding

TopoisomerasellBeta in Myeloid Differentiation by RetionidsR01CA117928 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI GANAPATHI, RAM N. · 2006 to 2010
$1.3M
NCI NIH HHS R01 CA 117928NCI NIH HHS R01 CA117928
6 · The paper itself

Abstract

Topoisomerase (topo) II catalyzes topological changes in DNA. Although both human isozymes, topo IIα and β are phosphorylated, site-specific phosphorylation of topo IIβ is poorly characterized. Using LC-MS/MS analysis of topo IIβ, cleaved with trypsin, Arg C or cyanogen bromide (CNBr) plus trypsin, we detected four +80-Da modified sites: tyr656, ser1395, thr1426 and ser1545. Phosphorylation at ser1395, thr1426 and ser1545 was established based on neutral loss of H(3) PO(4) (-98 Da) in the CID spectra and on differences in 2-D-phosphopeptide maps of (32) P-labeled wild-type (WT) and S1395A or T1426A/S1545A mutant topo IIβ. However, phosphorylation at tyr656 could not be verified by 2-D-phosphopeptide mapping of (32) P-labeled WT and Y656F mutant protein or by Western blotting with phosphotyrosine-specific antibodies. Since the +80-Da modification on tyr656 was observed exclusively during cleavage with CNBr and trypsin, this modification likely represented bromination, which occurred during CNBr cleavage. Re-evaluation of the CID spectra identified +78/+80-Da fragment ions in CID spectra of two peptides containing tyr656 and tyr711, confirming bromination. Interestingly, mutation of only tyr656, but not ser1395, thr1326 or ser1545, decreased topo IIβ activity, suggesting a functional role for tyr656. These results, while identifying an important tyrosine in topo IIβ, underscore the importance of careful interpretation of modifications having the same nominal mass.

Indexed as

ArtifactsAntibodies, Phospho-SpecificBiocatalysisBlotting, WesternCircular DichroismCyanogen BromideDNADNA-Binding ProteinsDNA Topoisomerases, Type IIHalogenationHL-60 CellsHumansIsoenzymesModels, MolecularMutationPhosphorylationAntibodies, Phospho-SpecificCyanogen BromideDNADNA-Binding ProteinsDNA Topoisomerases, Type IIIsoenzymesRecombinant ProteinsSerineThreonineTrypsinTyrosine

Identifiers

PMID21280220
PMCPMC3608106

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.